
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI
[ Wed, Feb 24th 2021 ]: WOPRAI

[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI
[ Tue, Feb 23rd 2021 ]: WOPRAI

[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
[ Mon, Feb 22nd 2021 ]: WOPRAI
Charles Duncan Reiterated (AVXL) at Buy with Increased Target to $25 on, Feb 23rd, 2021


🞛 This publication is a summary or evaluation of another publication
Charles Duncan of Cantor Fitzgerald, Reiterated "Anavex Life Sciences Corp." (AVXL) at Buy with Increased Target from $10 to $25 on, Feb 23rd, 2021.
Charles has made no other calls on AVXL in the last 4 months.
There is 1 other peer that has a rating on AVXL. Out of the 1 peers that are also analyzing AVXL, 0 agree with Charles's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charles
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $17 on, Wednesday, December 16th, 2020